Uricase from Candida sp., recombinant, expressed in E. coli, lyophilized powder, >=2 units/mg solid

Code: u0880-250un D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Suitable for the determination of uric acid in clinical analysis.

General description

Uricase deficient mice develop uric...


read more

Your Price
£165.00 EACH

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Suitable for the determination of uric acid in clinical analysis.

General description

Uricase deficient mice develop uric acid nephropathy and diabetes insipidus which can be mitigated with recombinant uricase treatment.

Packaging

250, 1000 units in glass bottle

Physical form

Powder; contains citrate and sucrose

Unit Definition

One unit will oxidize 1.0 µmole of uric acid to allantoin per minute at pH 8.5 at 25 °C.

formlyophilized powder
InChI keyVPXDHZMLJOJKOX-UHFFFAOYSA-N
InChI1S/C18H23N4O14P.H3N/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29;/h1-4,7-8,11-16,23,26-28H,5-6H2,(H,31,32)(H,19,24,29)(H,20,25,30);1H3
mol wt35 kDa by SDS-PAGE
Quality Level200
recombinantexpressed in E. coli
specific activity≥2 units/mg solid
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
Cas Number9002-12-4
This product has met the following criteria: